Pharmaceutical formulations and medicines focusing on various therapeutic areas in India.
Annual revenue $1.2M Latest available
Total funding - Funding intelligence
Employees 9 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Exmobiogenics

Exmobiogenics is a company based in India. The company has 9 employees as of April 05, 2024. Exmobiogenics offers products and services including Cardiovascular Medicines and Respiratory Medicines.

  • Headquarter India
  • Employees 9 as on 05 Apr, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Social
    Locked
  • Legal Name Exmo Biogenics Private Limited
  • Date of Incorporation 25 Feb, 2013
  • Jurisdiction Thrissur, Kerala, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.2 M (USD)
    45.8
    as on Mar 31, 2022
  • Net Profit
    $71.15 K (USD)
    58.33
    as on Mar 31, 2022
  • EBITDA
    -$35.35 K (USD)
    -81.29
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    9

    as on Apr 05, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Exmobiogenics

Exmobiogenics offers a comprehensive portfolio of products and services, including Cardiovascular Medicines and Respiratory Medicines.

Product name locked
Category locked
Primary

Formulations for cardiovascular care are developed and supplied by Exmo Biogenics Pvt. Ltd. to address related health needs.

Product name locked
Category locked
Locked

Formulations for respiratory conditions are provided by Exmo Biogenics Pvt. Ltd. as part of their product offerings.

Funding Insights of Exmobiogenics

Premium access

Detailed funding history for Exmobiogenics

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Exmobiogenics

Investments
Premium access

Investment portfolio details for Exmobiogenics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Exmobiogenics

Premium access

Detailed financials for Exmobiogenics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Exmobiogenics Comparisons

Exmobiogenics Primary company
Description
Pharmaceutical formulations and medicines focusing on variou...
Location
India
Founded Year
-
Annual Revenue
$1.2 M (USD)
Net Profit
$71.15 K (USD)
EBITDA
-$35.35 K (USD)
Employees
9
As of 2024
Premium access

Peer comparison for Exmobiogenics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Exmobiogenics

Premium access

Detailed competitors of Exmobiogenics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Exmobiogenics

Premium access

Complete news archive for Exmobiogenics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Exmobiogenics

Exmobiogenics is headquartered in India.

As of Apr 05, 2024, the latest employee count at Exmobiogenics is 9.

Annual revenue of Exmobiogenics is $1.2M as on Mar 31, 2022.

Exmo Biogenics Pvt. Ltd. is positioned as a pharmaceutical entity that strives to achieve fast growth within the Indian market. Quality-driven and technologically advanced formulations are utilized by the company to excel in life care initiatives. A commitment to providing innovative, effective, safe, and affordable medicines is demonstrated, aiming to contribute to a healthier future for humanity. Products encompass categories such as cardiovascular, respiratory, anti-infective agents, immunosuppressants, supplements, pain management, wound healing, antiulcerants, and antidiabetics. Operations are based in Mumbai, where efforts are directed towards meeting global health needs through reliable pharmaceutical solutions.

Exmobiogenics offers Cardiovascular Medicines and Respiratory Medicines.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available